Myeloproliferative neoplasms with calreticulin mutations exhibit distinctive morphologic features

6Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: Calreticulin (CALR) mutations are present in 50% to 85% of JAK2/MPL wild-type (wt) myeloproliferative neoplasms (MPNs). The histopathologic features of CALRmutated MPNs are unknown. Methods: We identified 71 patients with essential thrombocythemia (ET), primary myelofibrosis (PMF), and post-essential thrombocythemia myelofibrosis (post-ET MF) with available CALR status. CALR was assessed using capillary electrophoresis followed by Sanger sequencing confirmation. CALR status was correlated with histopathologic features. Results: The megakaryocytes of CALR-mutated PMF more often were hyperchromatic (20/21) compared with CALRwt cases (10/14) (P =.05). CALR-mutated ET showed more megakaryocytic clustering (7/7) compared with CALR-wt cases (5/9) (P=.03). Megakaryocytes of CALR-mutated post-ET MF (8/8) had a predominance of convoluted nuclei compared with CALR-wt cases (2/4) (P =.03). CALR mutations were more frequent in post-ET MF compared with ET (P =.04). Conclusions: CALR-mutated MPNs have a higher frequency of megakaryocytic aberrancies compared with CALR-wt cases. Patients with CALR-mutated ET appear to be more likely to develop myelofibrosis compared with patients with wt CALR.

Cite

CITATION STYLE

APA

Loghavi, S., Bueso-Ramos, C. E., Kanagal-Shamanna, R., Ok, C. Y., Salim, A. A., Routbort, M. J., … Patel, K. P. (2016). Myeloproliferative neoplasms with calreticulin mutations exhibit distinctive morphologic features. American Journal of Clinical Pathology, 145(3), 418–427. https://doi.org/10.1093/ajcp/aqw005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free